Gene Amplification technology is one of the rapidly growing markets in life science field. By the year 2015, global market for Gene Amplification technologies is projected to reach $2.2 billion. Major factors that continue to affect the industry are patent expiry, and competitive advantages associated with the existing and emerging technologies.
San Jose, CA (PRWEB) November 4, 2008 -- Molecular diagnostics and the Human Genome Project (HGP) have been the major growth drivers for gene amplification technology. Amplification is a mechanism by which cells are amplified or synthesized from a single copy of gene. Gene amplification technology addresses applications in molecular biology research (DNA amplification), gene therapy, drug discovery, forensic identification, and diagnosis.
World gene amplification technologies market is dominated by United States, Europe, and Japan, accounting for 90% of the world market in 2008, as stated in a recent report published by Global Industry Analysts, Inc. United States represents the most sought after market in terms of both market size and growth opportunities, with a projected CAGR of more than 7.5% over the period through 2015.
Polymerase Chain Reaction (PCR) dominates the global gene therapy market, with revenues estimated at US$864 million in 2008. However, growth in the PCR market is projected to slide down in the near term in wake of increasing applications and development of alternative technologies that challenge PCR in several areas. Alternative technologies to PCR are forecas
Copyright©2008 Vocus, Inc.
All rights reserved